GenMark Diagnostics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2014
Full year 2014 revenue is expected to be $30.6 million, an increase of 59% against 2013 base business revenue, which excludes former customer NMTC.
1st Jan change | Capi. | |
---|---|---|
+8.00% | 19TCr | |
+31.86% | 16TCr | |
+33.21% | 11TCr | |
+2.28% | 6.43TCr | |
+21.14% | 5.57TCr | |
+0.11% | 4.84TCr | |
-6.76% | 3.78TCr | |
+0.78% | 3.56TCr | |
+11.28% | 2.81TCr |